Minerva Surgical needs less than $6,000 from tying up a $25.5 million equity funding round in support of its endometrial ablation technology.
California women's health company Minerva Surgical is just a stone's throw from wrapping up an equity funding round slated to bring in $25.6 million.
Abbott Vascular plans to shutter a plant in Texas that makes its Supera peripheral stents as it shifts production and 50 jobs to another plant in California.
Medical aesthetics company Sientra files registration documents for an initial public offering proposed to raise as much as $86.3 million.
California medical device maker Sientra Inc. is looking to hit the public markets with an initial public offering that could raise as much as $86.3 million, according to an SEC filing.
Ivantis takes its Series B round to $71 million with another $25 million tranche as it looks to get its Hydrus micro-stent for glaucoma on the U.S. market.
Ivantis today said it added a $25 million tranche to its now $71 million Series B round as the Irvine, Calif.-based company looks to bring its miniature glaucoma scaffold to the U.S. market.
A coalition of life sciences lobbying groups bands together to demand more clarity from laws aiming to add transparency to physician-industry relationships.
Medicare's Sunshine Act database is slated to go public later this month with a year's worth of data on industry relationships with physicians, but an alliance of life sciences groups is calling for some sunshine of its own.
Here's a look at some of the top regulatory stories for medical device companies this week: Boston Scientific wins CE Mark for Vercise brain stim device; 20 Years of Improving Women's Health; Medtronic wins CE Mark for Tyrx cardiac device envelope; VertiFlex lands FDA panel date for Superion interspinous spacer
New rules on inversion mergers announced yesterday by the U.S. Treasury Dept. send shares of Medtronic and Covidien down as questions swirl about the impact ion their pending $43 billion merger.
